내분비-대사분과 - 대한내과학회
내분비-대사분과 - 대한내과학회
내분비-대사분과 - 대한내과학회
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>내분비</strong><strong>대사분과</strong> 589<br />
표 7. Suggested treatment goals in patients with CMR and lipoprotein abnormalities<br />
Highest-risk patients, including those with<br />
1) known CVD or 2) diabetes plus one or<br />
more additional major CVD risk factor<br />
Highest-risk patients, including those with<br />
1) no diabetes or known clinical CVD but<br />
two or more additional major CVD risk<br />
factors or 2) diabetes but no other major<br />
CVD risk factors<br />
LDL<br />
cholesterol<br />
(mg/dL)<br />
Goals<br />
Non-HDL<br />
cholesterol<br />
(mg/dL)<br />
ApoB<br />
(mg/dL)<br />
Change language